Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications studying cancer adverse outcome nononcological therapies review food drug
Assessing the Quality of Data from Stated-Preference Surveys See the research: Performance of a comprehension question in discrete-choice experiment surveys (DCE) Mansfield C, Poulos C, Boeri M, Hauber B Transcript: Developing methods to assess the …
… in the evaluation, selection, and development of clinical outcome assessments (COAs), particularly those assessing … outcomes assessment in several areas, including multiple cancer types and autoimmune, cardiovascular, and neurometabolic conditions, cellular and gene therapies, and study endpoints based on digital health …
Rare Diseases A Wealth of Experience We have collaborated with our clients on projects to research rare diseases, rare disease treatment, and complications and comorbidities of rare diseases. Our experience includes: Acromegaly Amyotrophic lateral …
… loss with teriflunomide versus other disease-modifying therapies in relapsing multiple sclerosis: a systematic review and network meta-analysis. Ainsworth C , Higuchi K, …
… novel approaches to the development of new cardiovascular therapies,” explains Dr. Mangel. The theory that the aorta …
… Access and Outcomes Strategy Telecommuter - USA MSc, Food Science and Human Nutrition BA, Technical Journalism and … and higher education industries. She has 25 peer-reviewed publications in scientific journals and has delivered …
… Surveys and Observational Studies, Market Access and Outcome Strategies, and Health Economics. The focus of recent … therapeutic areas at various times for CfOR and supported drug development and commercialization processes in … understanding of the benefits, risks, and patient value of therapies. Prior to working at Amgen, she was involved in …
… Centers (CMSC) Annual Meeting. A systematic literature review of immunoglobulin levels among B-cell–depleting therapies and risk of infections in relapsing multiple …
… the validation and use of a wide variety of clinical outcome assessment instruments among patients. Ms. Pimienta’s … endpoints, and study design to generate evidence following Food and Drug Administration (FDA)/European Medicines Agency (EMA) …
… conditions, mental health, oncology and supportive therapies, and renal disease. Dr. Schwab has published in the American Health & Drug Benefits, BMJ Open Diabetes Research and Care, Clinical …